LM103 TILs Injection Clinical Trials

2 actively recruiting trials

▲ +1 trial since May 2026

Pipeline

Phase 2: 2

Top Sponsors

Suzhou BlueHorse Therapeutics Co., Ltd.2

Indications

Cancer2
Advanced Melanoma1
Lung Cancer1
Non Small Cell Lung Cancer1

Other2 trials

A Phase II Trial of LM103 for Adjuvant Treatment in Patients With Non-small Cell Lung Cancer

Phase 2

A Phase II Trial of LM103 in Advanced Melanoma

Phase 2

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.